 |
 |
 |
About Us |
|
|
|
|
Business Units |
|
|
|
|
Portfolio |
|
|
|
|
News |
|
|
|
Events |
|
|
|
|
Team |
|
|
|
|
Articles |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| Team > Board |
 |
D. Todd Dollinger, CEO and Chairman, The Trendlines Group; Chairman, Misgav Venture Accelerator
Steve Rhodes, Chairman and CEO, The Trendlines Group; Chairman, Mofet Venture Accelerator
Zeev Bronfeld, Director
Zeev has raised hundreds of millions of dollars for early-stage companies and has a proven track record of shareholder value creation and exits. He founded and serves as director of Biomedix (TASE: BMDX), a two-incubator holding company. He also founded Biocell (TASE: BCEL), a company specializing in biotechnology, where he has served as a director and CEO since 1986. He is also a director of D. Medical Industries (TASE: DMDC), and Protalix (AMEX: PLX). Zeev is a director of privately held Ecocycle Israel, Contipi, and L.N. Innovative Technologies.
He received a bachelor's degree in economics from the Hebrew University of Jerusalem.
Ehud Huberman, Director
Ehud Huberman is an attorney and a partner in the law firm of Sheptnisky, Halfin, and Huberman. He is a veteran entrepreneur and led the investment group that made the first private investment in an Israeli incubator in 1992. Ehud has been a member of the board of directors of Misgav Venture Accelerator since 1992 and of The Trendlines Group since its formation in 2007.
He received his law degree from Tel Aviv University.
Shimon Erlichman, Director
Former CTO of an Israeli government security organization, Shimon brings great technological depth and breadth of knowledge across numerous fields of science and technology. Shimon is a director of FTK Technologies.
He holds a bachelor's degree in electrical engineering from the Technion-Israel Institute of Technology.
|
|
|
|
